click below
click below
Normal Size Small Size show me how
Med/Sx Intro to Path
notes
Term | Definition |
---|---|
pathology | study of cause & nature of disease- including changes in structure & function. structure referring to anatomical changes & function physiological changes |
etiology | cause |
prognosis | what is the course and final outcome with or without rx |
primary prevention | stop process leading to dx, pathological condition. know risk factors: modifiable vs nonmodifiable. ID risk factors. remove/reduce risk factors w/ edu & lifestyle changes |
secondary prevention | early detection and rx w/ screening of high risk groups (ex. women w/ family hx of breast CA or middle aged women should be tested for breast CA) |
tertiary prevention | limit the degree of disability & increase function w/chronic/irreversible conditions |
rx | prevention, medical management:including medications, surgical management, PT rx per physical therapist POC |
Nagi Model (what does PT rx?) | we don't rx diagnoses or pathology- we rx functional limitations, physical impairments & disabilities that result |
preferred practice patterns (systems PT rx's) | musculoskeletal, neuromuscular, cardiopulmonary, integementary |
PT initial eval | 1)PMH 2)risk factor assessment 3)exam & eval 4)are pt's probs w/in scope of practice?a)develop PT dx/POC 5)look for comorbidities |
decisions to be made if there is a cluster of S&S that are not w/in PT scope of practice | 1)are they the result of other KNOWN comorbidities (concurrent pathologies) a) expected & stable: continue w/ rx & monitor for change b)unexpected, of concern: further screening, refer on before starting PT. 2)are they from unknown? basically same plan |